Skip to content

Intensity modulated radiation therapy for pleural recurrence of thymoma

Intensity modulated radiation therapy for pleural recurrence of thymoma

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002095
Enrollment
Unknown
Registered
2012-04-06
Start date
2009-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymoma

Interventions

1:intensity modulated radiation therapy (IMRT)

Sponsors

Department of Radiation Oncology,Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. pathologically diagnosed thymoma; 2. the primary tumor has been resected or well controlled by previous treatment; 3. pleural recurrence is decided by CT or other images; 4. age ranges between 18-70 years; 5. no other treatment was used within 3 months before RT; 6. enough cardiac-pulmonary function reservation; 7. KPS score>80.

Exclusion criteria

Exclusion criteria: 1. thymic carcinoma; 2. thoracic radiation has been given within 1 year; 3. the performance status is not good enough to endure RT.

Design outcomes

Primary

MeasureTime frame
local response rate;

Secondary

MeasureTime frame
progression free survival time;

Countries

China

Contacts

Public ContactWang Changlu
luise2w@msn.com+86 13817125147

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026